424 related articles for article (PubMed ID: 29250791)
21. Management of anti-Jka alloimmunization.
Franco A; Rossi K; Krugh D; O'Shaughnessy R
J Reprod Med; 2009 Mar; 54(3):121-5. PubMed ID: 19370894
[TBL] [Abstract][Full Text] [Related]
22. Treatment of D alloimmunization in pregnancy with plasmapheresis and intravenous immune globulin: case report.
Fernández Alba JJ; León R; González-Macías C; Paz A; Prado F; Moreno LJ; Torrejón R
Transfus Apher Sci; 2014 Aug; 51(1):70-2. PubMed ID: 25312036
[TBL] [Abstract][Full Text] [Related]
23. A case of severe Rh (D) alloimmunization treated by intensive plasma exchange and high-dose intravenous immunoglobulin.
Palfi M; Hildén JO; Matthiesen L; Selbing A; Berlin G
Transfus Apher Sci; 2006 Oct; 35(2):131-6. PubMed ID: 17045529
[TBL] [Abstract][Full Text] [Related]
24. Clinical Characteristics of Jra Alloimmunization in Pregnancy: A Case Series.
Kanagawa T; Fujikawa E; Mimura K; Endo M; Sasahara J; Kimura T; Mitsuda N; Ishii K
Fetal Diagn Ther; 2019; 46(6):433-439. PubMed ID: 31434085
[TBL] [Abstract][Full Text] [Related]
25. Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.
Zwiers C; van der Bom JG; van Kamp IL; van Geloven N; Lopriore E; Smoleniec J; Devlieger R; Sim PE; Ledingham MA; Tiblad E; Moise KJ; Gloning KP; Kilby MD; Overton TG; Jørgensen DS; Schou KV; Paek B; Walker M; Parry E; Oepkes D; de Haas M
Am J Obstet Gynecol; 2018 Sep; 219(3):291.e1-291.e9. PubMed ID: 29902448
[TBL] [Abstract][Full Text] [Related]
26. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
27. A case of D alloimmunization in pregnancy: successfully treated solely with therapeutic plasma exchange (TPE).
Tara F; Maleki A; Taheri N; Moein Darbari S
J Blood Med; 2019; 10():251-253. PubMed ID: 31440110
[TBL] [Abstract][Full Text] [Related]
28. Fetal and neonatal outcome in severe alloimmunization managed with intrauterine transfusion: 18-year experience in a tertiary referral hospital in China.
Pan W; Wu H; Chen J; Mo X; Wang H; Fang Q; Li Y; Huang Y
Front Pediatr; 2023; 11():1157004. PubMed ID: 37124190
[TBL] [Abstract][Full Text] [Related]
29. A new preparation method for red blood cells for intrauterine transfusion enabling reduction of donor exposure.
Bontekoe IJ; Scharenberg J; Schonewille H; Zwaginga JJ; Brand A; van der Meer PF; de Korte D
Transfusion; 2015 Jul; 55(7):1693-9. PubMed ID: 25656421
[TBL] [Abstract][Full Text] [Related]
30. Outcome predictors for maternal red blood cell alloimmunisation with anti-K and anti-D managed with intrauterine blood transfusion.
Vlachodimitropoulou E; Garbowski M; Anne Solomon S; Abbasi N; Seaward G; Windrim R; Keunen J; Kelly E; Van Mieghem T; Shehata N; Ryan G
Br J Haematol; 2022 Feb; 196(4):1096-1104. PubMed ID: 34862601
[TBL] [Abstract][Full Text] [Related]
31. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
[TBL] [Abstract][Full Text] [Related]
32. Management of pregnancies complicated by anti-E alloimmunization.
Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
[TBL] [Abstract][Full Text] [Related]
33. Management of red blood cell alloimmunization in pregnancy.
Ghesquière L; Garabedian C; Coulon C; Verpillat P; Rakza T; Wibaut B; Delsalle A; Subtil D; Vaast P; Debarge V
J Gynecol Obstet Hum Reprod; 2018 May; 47(5):197-204. PubMed ID: 29476829
[TBL] [Abstract][Full Text] [Related]
34. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
[TBL] [Abstract][Full Text] [Related]
35. Provision of KEL1-negative blood to obstetric patients: a 3-year single-institution retrospective review.
O'Brien KL; Kim YA; Haspel RL; Uhl L
Transfusion; 2015 Mar; 55(3):599-604; quiz 598. PubMed ID: 25118004
[TBL] [Abstract][Full Text] [Related]
36. Long-Term follow up after intra-Uterine transfusionS; the LOTUS study.
Verduin EP; Lindenburg IT; Smits-Wintjens VE; van Klink JM; Schonewille H; van Kamp IL; Oepkes D; Walther FJ; Kanhai HH; Doxiadis II; Lopriore E; Brand A
BMC Pregnancy Childbirth; 2010 Dec; 10():77. PubMed ID: 21122095
[TBL] [Abstract][Full Text] [Related]
37. Impact of red blood cell alloimmunization on fetal and neonatal outcomes: A single center cohort study.
Lieberman L; Callum J; Cohen R; Cserti-Gazdewich C; Ladhani NNN; Buckstein J; Pendergrast J; Lin Y
Transfusion; 2020 Nov; 60(11):2537-2546. PubMed ID: 32893897
[TBL] [Abstract][Full Text] [Related]
38. Antenatal maternal administration of phenobarbital for the prevention of exchange transfusion in neonates with hemolytic disease of the fetus and newborn.
Trevett TN; Dorman K; Lamvu G; Moise KJ
Am J Obstet Gynecol; 2005 Feb; 192(2):478-82. PubMed ID: 15695990
[TBL] [Abstract][Full Text] [Related]
39. Successful treatment of extremely severe fetal anemia due to Kell alloimmunization.
Collinet P; Subtil D; Puech F; Vaast P
Obstet Gynecol; 2002 Nov; 100(5 Pt 2):1102-5. PubMed ID: 12423822
[TBL] [Abstract][Full Text] [Related]
40. Intravenous immunoglobulin in the management of severe early onset red blood cell alloimmunisation.
Vlachodimitropoulou E; Lo TK; Bambao C; Denomme G; Seaward GR; Windrim R; Tessier F; Kelly E; Van Mieghem T; Ryan G
Br J Haematol; 2023 Jan; 200(1):100-106. PubMed ID: 36100813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]